SEARCH

SEARCH BY CITATION

References

  • Baukrowitz T & Yellen G (1995). Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms. Neuron 15, 951960.
  • Bett GC, Morales MJ, Strauss HC & Rasmusson RL (2006). KChIP2b modulates the affinity and use-dependent block of Kv4.3 by nifedipine. Biochem Biophys Res Commun 340, 11671177.
  • Bett GC & Rasmusson RL (2004). Inactivation and recovery in Kv1.4 K+ channels: lipophilic interactions at the intracellular mouth of the pore. J Physiol 556, 109120.
  • Bleich M, Briel M, Busch AE, Lang HJ, Gerlach U, Gogelein H, Greger R & Kunzelmann K (1997). KVLQT channels are inhibited by the K+ channel blocker 293B. Pflugers Arch 434, 499501.
  • Brahmajothi MV, Morales MJ, Liu S, Rasmusson RL, Campbell DL & Strauss HC (1996). In situ hybridization reveals extensive diversity of K+ channel mRNA in isolated ferret cardiac myocytes. Circulation Res 78, 10831089.
  • Chouabe C, Neyroud N, Guicheney P, Lazdunski M, Romey G & Barhanin J (1997). Properties of KvLQT1 K+ channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J 16, 54725479.
  • Demolombe S, Franco D, De Boer P, Kuperschmidt S, Roden D, Pereon Y, Jarry A, Moorman AF & Escande D (2001). Differential expression of KvLQT1 and its regulator IsK in mouse epithelia. Am J Physiol Cell Physiol 280, C359C372.
  • Gould TD & Pfeifer K (1998). Imprinting of mouse Kvlqt1 is developmentally regulated. Hum Mol Genet 7, 483487.
  • Jentsch TJ (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nat Rev Neurosci 1, 2130.
  • Lan WZ, Abbas H, Lemay AM, Briggs MM & Hill CE (2005). Electrophysiological and molecular identification of hepatocellular volume-activated K+ channels. Biochim Biophys Acta 1668, 223233.
  • Mason DE, Mitchell KE, Li Y, Finley MR & Freeman LC (2002). Molecular basis of voltage-dependent potassium currents in porcine granulosa cells. Mol Pharmacol 61, 201213.
  • Melman YF, De La Domenech A, LS & McDonald TV (2001). Structural determinants of KvLQT1 control by the KCNE family of proteins. J Biol Chem 276, 64396444.
  • Melman YF, Krumerman A & McDonald TV (2002). A single transmembrane site in the KCNE-encoded proteins controls the specificity of KvLQT1 channel gating. J Biol Chem 277, 2518725194.
  • Melman YF, Um SY, Krumerman A, Kagan A & McDonald TV (2004). KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron 42, 927937.
  • Neyroud N, Tesson F, Denjoy I, Leibovici M, Donger C, Barhanin J, Faure S, Gary F, Coumel P, Petit C, Schwartz K & Guicheney P (1997). A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat Genet 15, 186189.
  • Panaghie G, Tai KK & Abbott GW (2006). Interaction of KCNE subunits with the KCNQ1 K+ channel pore. J Physiol 570, 455467.
  • Pusch M, Ferrera L & Friedrich T (2001). Two open states and rate-limiting gating steps revealed by intracellular Na+ block of human KCNQ1 and KCNQ1/KCNE1 K+ channels. J Physiol 533, 135143.
  • Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL & Keating MT (1996). Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature 384, 8083.
  • Schroeder BC, Waldegger S, Fehr S, Bleich M, Warth R, Greger R & Jentsch TJ (2000). A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 403, 196199.
  • Seebohm G, Chen J, Strutz N, Culberson C, Lerche C & Sanguinetti MC (2003a). Molecular determinants of KCNQ1 channel block by a benzodiazepine. Mol Pharmacol 64, 7077.
  • Seebohm G, Lerche C, Pusch M, Steinmeyer K, Bruggemann A & Busch AE (2001a). A kinetic study on the stereospecific inhibition of KCNQ1 and IKs by the chromanol 293B. Br J Pharmacol 134, 16471654.
  • Seebohm G, Sanguinetti MC & Pusch M (2003b). Tight coupling of rubidium conductance and inactivation in human KCNQ1 potassium channels. J Physiol 552, 369378.
  • Seebohm G, Scherer CR, Busch AE & Lerche C (2001b). Identification of specific pore residues mediating KCNQ1 inactivation. A novel mechanism for long QT syndrome. J Biol Chem 276, 1360013605.
  • Seebohm G, Strutz-Seebohm N, Ureche ON, Baltaev R, Lampert A, Kornichuk G, Kamiya K, Wuttke TV, Lerche H, Sanguinetti MC & Lang F (2006). Differential roles of S6 domain hinges in the gating of KCNQ potassium channels. Biophys J 90, 22352244.
  • Seebohm G, Westenskow P, Lang F & Sanguinetti MC (2005). Mutation of colocalized residues of the pore helix and transmembrane segments S5 and S6 disrupt deactivation and modify inactivation of KCNQ1 K+ channels. J Physiol 563, 359368.
  • Tamkun MM, Knittle TJ, Deal KK, House MH, Roberds SL, Po S, Bennett PB, George AL Jr & Snyders DJ (1994). Molecular physiology of voltage-gated potassium and sodium channels: Ion channel diversity within the cardiovascular system. In Ion Channels in the Cardiovascular System, ed. Spooner PM, Brown AM, Catterall WA, Kaczorowski GJ & Strauss HC, pp. 287316. Futura Publishing Co., Inc., Armonk , NY .
  • Tristani-Firouzi M & Sanguinetti MC (1998). Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits. J Physiol 510, 3745.
  • Tsevi I, Vicente R, Grande M, Lopez-Iglesias C, Figueras A, Capella G, Condom E & Felipe A (2005). KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies. J Cell Physiol 202, 400410.
  • Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, Marcus DC, Lazdunski M, Heinemann SF & Barhanin J (1996). Inner ear defects induced by null mutation of the isk gene. Neuron 17, 12511264.
  • Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ et al. (1996). Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genet 12, 1723.
  • Wang S, Morales MJ, Liu S, Strauss HC & Rasmusson RL (1997). Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation. FEBS Lett 417, 4347.
  • Wang S, Morales MJ, Qu YJ, Bett GC, Strauss HC & Rasmusson RL (2003). Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect. J Physiol 546, 387401.
  • Wulfsen I, Hauber HP, Schiemann D, Bauer CK & Schwarz JR (2000). Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary. J Neuroendocrinol 12, 263272.
  • Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY & Blanar MA (1997). KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A 94, 40174021.
  • Yeola SW, Rich TC, Uebele VN, Tamkun MM & Snyders DJ (1996). Molecular analysis of a binding site for quinidine in a human cardiac delayed rectifier K+ channel. Role of S6 in antiarrhythmic drug binding. Circulation Res 78, 11051114.
  • Zhou M, Morais-Cabral JH, Mann S & MacKinnon R (2001). Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 411, 657661.